E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Depression > The Pain of Bipolar Depression Disorder

Tags

  • energy
  • diagnostic
  • devices
  • depressive episodes
  • developing combination
  • combination products

  • Links

  • Health Insurance - It's Important To Know What's Not Insured!
  • The Biggest Mistake When Shopping For A Mortgage, Part I
  • How Folic Acid Helps Reduce the Risk of Birth Defects
  • E-Articles - The Pain of Bipolar Depression Disorder

    Bipolar depression disorder generally occurs before the age of 30 years and may first develop during adolescence, but most commonly presents its symptoms in the l
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ate teens and early 20s. It is a type of mood disorder that exhibits marked changes in mood between extreme elation or happiness and severe depression. Bipolar di
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    sorder used to be referred to as manic depression.

    Like other mental illnesses, bipolar disorder cannot yet be identified physiologically—for example, through a
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    blood test or a brain scan. Therefore, a diagnosis of bipolar disorder is made on the basis of symptoms, course of illness, and, when available, family history.
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    The diagnostic criteria for bipolar disorder are described in the Diagnostic and Statistical Manual for Mental Disorders, fourth edition (DSM-IV).

    A person with
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    bipolar depression disorder experiences cycling moods that usually swing from being overly elated or irritable (mania) to sad and hopeless (depression) and then
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    back again, with periods of normal moods in between. There are statistics that say that one in five people will suffer from depression at least once during their
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    life.

    Symptoms of depression include: loss of interest in usual activities, prolonged sad or irritable mood, loss of energy or fatigue, feelings of guilt or wort
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    hlessness, sleeping too much or inability to sleep, drop in grades and inability to concentrate, inability to experience pleasure, appetite loss or overeating, an
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ger, worry, and anxiety, thoughts of death or suicide.

    Symptoms of manic states are varied and include restlessness, increased energy, euphoric mood, racing thou
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ghts, poor judgment, intrusive or provocative behavior, difficulty concentrating, and a decreased need for sleep.

    The exact causes of bipolar disorder aren't kno
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    wn, but stressful life events, un-resolvable problems, or emotional damage in childhood, possibly combined with genetic factors may play a role. Scientists are al
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    so studying about the possible causes of bipolar disorder through several kinds of studies. As the causes are more clearly identified and defined through research
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    , scientists will gain a better understanding of the underlying causes of the illness, and eventually may be able to predict which types of treatment will work mo
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    st effectively. As it stands now it is thought that bipolar depression disorder is caused by electrical and chemical processes in the brain not functioning correc
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    tly.

    Unfortunately, for most individuals, lifelong treatment may be required to prevent recurrent manic and depressive episodes. They should try to identify the
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    features of the illness that are distinct to that individual, including the warning signs of recurrent manic or depressive episodes, so that someone in treatment
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    can get immediate help to ward off those symptoms. Failure to seek help can lead to suicide so the most important factor in any treatment is the sufferer's accept
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ance of some form of counseling and/ or medication.

    Bipolar depression disorder is a serious mental illness that can be successfully treated with proper psycholo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    gical counseling and medication. It is important that anyone exhibiting the signs or symptoms of this disease seek help so they can properly manage this condition


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/238762/e-article-The-Pain-of-Bipolar-Depression-Disorder.html">The Pain of Bipolar Depression Disorder</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/238762/e-article-The-Pain-of-Bipolar-Depression-Disorder.html]The Pain of Bipolar Depression Disorder[/url]

    Related Articles:

    The Internet and Beyond - 12 Tips on Writing Better Brochures

    Business Promotional Items - How to Stimulate Word of Mouth Advertising

    Hero's Journey (Monomyth): Transformation is the Secret, Not Conflict

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com